REFERENCES
- Williams R, Alisa A, Karani J, et al. Living related adult-to-adult liver transplantation: meeting the donor shortage. Antivi Res 2001; 52: 217–223
- Broelsch C E, Emond J C, Thistlethwaite J R, et al. Liver transplantation, including the concept of reduced-size liver transplants in children. Ann Surg 1988; 208(4)410–420
- Malago M, Rogiers X, Broelsch C E. Reduced-size hepatic allografts. Annu Rev Med 1995; 46: 507–512
- Yi N J, Suh K S, Cho J Y, et al. Three-quarters of right liver donors experienced postoperative complications. Liver Transpl 2007; 13(6)797–806
- Middleton P F, Duffield M, Lynch S V, et al. Living donor liver transplantation–adult donor outcomes: a systematic review. Liver Transpl 2006; 12(1)24–30
- Tanaka K, Ogura Y. “Small-for-size graft” and “small-for-size syndrome” in living donor liver transplantation. Yonsei Med J 2004; 45(6)1089–1094
- Kamada N, Calne R Y. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28(1)47–50
- Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997; 25(3)658–663
- Ormonde D G, de Boer W B, Kierath A, et al. Banff schema for grading liver allograft rejection: utility in clinical practice. Liver Transpl Surg 1999; 5(4)261–268
- Zweig M H, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39(4)561–577
- Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991–1045
- Matzinger P. An innate sense of danger. Semin Immunol 1998; 10(5)399–415
- Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13(1)114–119
- Bourdeaux C, Darwish A, Jamart J, et al. Living-related versus deceased donor pediatric liver transplantation: a multivariate analysis of technical and immunological complications in 235 recipients. Am J Transpl 2007; 7(2)440–447
- Olthoff K M, Merion R M, Ghobrial R M, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 2005; 242(3)314–23, discussion
- Marcos A. Right lobe living donor liver transplantation: a review. Liver Transpl 2000; 6(1)3–20
- Dahm F, Georgiev P, Clavien P A. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transpl 2005; 5(11)2605–2610
- Kamada N. The immunology of experimental liver transplantation in the rat. Immunology 1985; 55(3)369–389
- Shiraishi M, Csete M E, Yasunaga C, et al. Regeneration-induced accelerated rejection in reduced-size liver grafts. Transplantation 1994; 57(3)336–340
- Astarcioglu I, Cursio R, Reynes M, et al. Increased risk of antibody-mediated rejection of reduced-size liver allografts. J Surg Res 1999; 87(2)258–262
- Omura T, Nakagawa T, Randall H B, et al. Increased immune responses to regenerating partial liver grafts in the rat. J Surg Res 1997; 70(1)34–40
- Kamada N, Calne R Y. Orthotopic liver transplantation in the rat. Technique using cuff for portal vein anastomosis and biliary drainage. Transplantation 1979; 28(1)47–50
- Dahmen U, Tanigawa T, Doebel L, et al. Effective immune transfer but also induction of rejection are consequences of using grafts from highly immunized donors. Graft 2002; 5: 236–243
- Tanigawa T, Dahmen U, Dirsch O, et al. Nonspecific repeated skin graft sensitization induces liver allograft rejection in a spontaneously tolerant liver allograft model. Transpl Proc 1997; 29(1–2)1047–1049
- Meyer D, Löffeler S, Otto C, et al. Donor-derived alloantigen-presenting cells persist in the liver allograft during tolerance induction. Transpl Int 2000; 13(1)12–20
- Thai N L, Li Y, Fu F, et al. Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection. Liver Transpl Surg 1997; 3(2)118–129
- Tian Y, Graf R, Jochum W, et al. Arterialized partial orthotopic liver transplantation in the mouse: a new model and evaluation of the critical liver mass. Liver Transpl 2003; 9(8)789–795
- Hobart M, Ramassar V, Goes N, et al. The induction of class I and II major histocompatibility complex by allogeneic stimulation is dependent on the transcription factor interferon regulatory factor 1 (IRF-1): observations in IRF-1 knockout mice. Transplantation 1996; 62(12)1895–1901
- Heelan B T, Thompson M, McCormack A, et al. The kinetics of MHC class I and class II expression in rat renal allografts. Transplantation 1996; 61(8)1274–1277